Bottom line
How much do FHLC and PINK overlap?
41% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 50.0% of FHLC's assets and 40.1% of PINK's. They share a meaningful core but differ in the rest of the portfolio.
FHLC holds far more positions (337 vs 54), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FHLC and PINK have in common
| Holding | % of FHLC | % of PINK | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.35% | 5.91% | 5.91% |
| Johnson & Johnson | 8.93% | 5.45% | 5.45% |
| AbbVie Inc | 6.42% | 4.52% | 4.52% |
| UnitedHealth Group Inc | 5.44% | 5.76% | 5.44% |
| Thermo Fisher Scientific Inc | 3.09% | 3.23% | 3.09% |
| Amgen Inc | 3.00% | 2.12% | 2.12% |
| Gilead Sciences Inc | 2.34% | 2.87% | 2.34% |
| CVS Health Corp | 1.92% | 2.01% | 1.92% |
| Danaher Corp | 1.80% | 2.28% | 1.80% |
| Vertex Pharmaceuticals Inc | 1.76% | 1.45% | 1.45% |
| Elevance Health Inc | 1.19% | 2.73% | 1.19% |
| Cardinal Health Inc | 0.78% | 1.78% | 0.78% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FHLC
- Merck & Co Inc — 4.66%
- Abbott Laboratories — 2.66%
- Pfizer Inc — 2.06%
- Bristol-Myers Squibb Co — 1.93%
- Intuitive Surgical Inc — 1.82%
- Stryker Corp — 1.62%
- Medtronic PLC — 1.59%
- McKesson Corp — 1.52%
- Regeneron Pharmaceuticals Inc — 1.15%
- Cigna Group/The — 1.06%
- Boston Scientific Corp — 1.00%
- HCA Healthcare Inc — 0.91%
- Cencora Inc — 0.83%
Only in PINK
- Purecycle Technologies Inc — 6.89%
- United Therapeutics Corp — 6.86%
- Novo Nordisk A/s — 6.75%
- Warby Parker Inc — 5.46%
- Jazz Pharmaceuticals Plc — 4.61%
- Biohaven Ltd — 4.32%
- Benitec Biopharma Inc — 3.75%
- Align Technology Inc — 3.14%
- 10x Genomics Inc — 3.13%
- Quest Diagnostics Inc — 2.94%
- Astrazeneca Plc — 1.81%
- Establishment Labs Holdings Inc — 1.45%
- Eyepoint Inc — 1.44%
Asset mix
| Asset type | FHLC | PINK |
|---|---|---|
| Stocks | 99.7% | 99.6% |
| Cash & short-term funds | 0.2% | 0.4% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | FHLC | PINK |
|---|---|---|
| US | 96.5% | 81.0% |
| DK | — | 6.8% |
| VG | — | 5.8% |
| IE | 2.2% | 4.7% |
| GB | 0.5% | 1.8% |
| BM | 0.2% | — |
| CA | 0.2% | — |
| CH | 0.1% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do FHLC and PINK overlap?
What stocks do FHLC and PINK have in common?
Should I own both FHLC and PINK?
Which holds more stocks, FHLC or PINK?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.